[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

AR218733A1 - Procedimiento para la preparacion de nuevos derivados de 1-(2,3-di(n-alquiloxi o n-alqueniloxi c12-c10)-propil)-4-aminometil-4-fenil-piperidina,y sus sales de adicion de acido farmaceuticamente aceptables,utiles para combatir las infecciones viricas en los mamiferos - Google Patents

Procedimiento para la preparacion de nuevos derivados de 1-(2,3-di(n-alquiloxi o n-alqueniloxi c12-c10)-propil)-4-aminometil-4-fenil-piperidina,y sus sales de adicion de acido farmaceuticamente aceptables,utiles para combatir las infecciones viricas en los mamiferos

Info

Publication number
AR218733A1
AR218733A1 AR276987A AR27698779A AR218733A1 AR 218733 A1 AR218733 A1 AR 218733A1 AR 276987 A AR276987 A AR 276987A AR 27698779 A AR27698779 A AR 27698779A AR 218733 A1 AR218733 A1 AR 218733A1
Authority
AR
Argentina
Prior art keywords
alquiloxi
alqueniloxi
aminometil
piperidina
propil
Prior art date
Application number
AR276987A
Other languages
English (en)
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Application granted granted Critical
Publication of AR218733A1 publication Critical patent/AR218733A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/12—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/18—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by etherified hydroxyl radicals
    • C07D303/20—Ethers with hydroxy compounds containing no oxirane rings
    • C07D303/24—Ethers with hydroxy compounds containing no oxirane rings with polyhydroxy compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/02—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C217/04—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C217/06—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted
    • C07C217/08—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to an acyclic carbon atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/02—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C217/04—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C217/28—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/02—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C217/48—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated and containing rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/54—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C217/56—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms
    • C07C217/58—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms with amino groups and the six-membered aromatic ring, or the condensed ring system containing that ring, bound to the same carbon atom of the carbon chain
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/54—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C217/56—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms
    • C07C217/62—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms linked by carbon chains having at least three carbon atoms between the amino groups and the six-membered aromatic ring or the condensed ring system containing that ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C257/00—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines
    • C07C257/10—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. amidines
    • C07C257/18—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. amidines having carbon atoms of amidino groups bound to carbon atoms of six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00—Ethers; Compounds having groups, groups or groups
    • C07C43/02—Ethers
    • C07C43/03—Ethers having all ether-oxygen atoms bound to acyclic carbon atoms
    • C07C43/14—Unsaturated ethers
    • C07C43/15—Unsaturated ethers containing only non-aromatic carbon-to-carbon double bonds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/44—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reduction and hydrolysis of nitriles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C47/00—Compounds having —CHO groups
    • C07C47/02—Saturated compounds having —CHO groups bound to acyclic carbon atoms or to hydrogen
    • C07C47/198—Saturated compounds having —CHO groups bound to acyclic carbon atoms or to hydrogen containing ether groups, groups, groups, or groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C47/00—Compounds having —CHO groups
    • C07C47/52—Compounds having —CHO groups bound to carbon atoms of six—membered aromatic rings
    • C07C47/575—Compounds having —CHO groups bound to carbon atoms of six—membered aromatic rings containing ether groups, groups, groups, or groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/125—Saturated compounds having only one carboxyl group and containing ether groups, groups, groups, or groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/26—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D211/62—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4
    • C07D211/64—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4 having an aryl radical as the second substituent in position 4

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AR276987A 1977-08-18 1979-06-21 Procedimiento para la preparacion de nuevos derivados de 1-(2,3-di(n-alquiloxi o n-alqueniloxi c12-c10)-propil)-4-aminometil-4-fenil-piperidina,y sus sales de adicion de acido farmaceuticamente aceptables,utiles para combatir las infecciones viricas en los mamiferos AR218733A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/825,535 US4166132A (en) 1977-08-18 1977-08-18 Antiviral amine derivatives of glycerol and propanediols

Publications (1)

Publication Number Publication Date
AR218733A1 true AR218733A1 (es) 1980-06-30

Family

ID=25244254

Family Applications (2)

Application Number Title Priority Date Filing Date
AR273345A AR219543A1 (es) 1977-08-18 1978-08-18 Procedimiento para la preparacion de un nuevo derivado aminico de di-o-(1-alquilo o alquenilo c12-c20)glicerol y sus sales de adicion de acido farmaceuticamente aceptables,utiles para combatir las infecciones viricas en los mamiferos
AR276987A AR218733A1 (es) 1977-08-18 1979-06-21 Procedimiento para la preparacion de nuevos derivados de 1-(2,3-di(n-alquiloxi o n-alqueniloxi c12-c10)-propil)-4-aminometil-4-fenil-piperidina,y sus sales de adicion de acido farmaceuticamente aceptables,utiles para combatir las infecciones viricas en los mamiferos

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AR273345A AR219543A1 (es) 1977-08-18 1978-08-18 Procedimiento para la preparacion de un nuevo derivado aminico de di-o-(1-alquilo o alquenilo c12-c20)glicerol y sus sales de adicion de acido farmaceuticamente aceptables,utiles para combatir las infecciones viricas en los mamiferos

Country Status (35)

Country Link
US (1) US4166132A (es)
JP (3) JPS5829939B2 (es)
AR (2) AR219543A1 (es)
AT (1) AT363922B (es)
AU (1) AU503079B1 (es)
BE (1) BE869793A (es)
CA (1) CA1102354A (es)
CH (1) CH634544A5 (es)
CS (1) CS208155B2 (es)
DD (2) DD148951A5 (es)
DE (3) DE2857416C2 (es)
DK (1) DK149022C (es)
EG (1) EG13438A (es)
ES (3) ES472659A1 (es)
FI (1) FI67687C (es)
FR (2) FR2421871A1 (es)
GB (1) GB2005248B (es)
GR (1) GR73154B (es)
HU (2) HU181238B (es)
IE (1) IE47151B1 (es)
IL (1) IL55370A (es)
IN (1) IN148386B (es)
IT (1) IT1098280B (es)
LU (1) LU80114A1 (es)
MX (1) MX6091E (es)
NL (1) NL176670C (es)
NO (3) NO147300C (es)
NZ (1) NZ188174A (es)
PH (4) PH16469A (es)
PL (3) PL116434B1 (es)
PT (1) PT68426A (es)
SE (3) SE447823B (es)
SU (3) SU893128A3 (es)
YU (3) YU41115B (es)
ZA (1) ZA783855B (es)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4173641A (en) * 1978-05-15 1979-11-06 Pfizer Inc. Di-O-n-alkyl glycerol derivatives as immune stimulants
YU41932B (en) * 1979-07-09 1988-02-29 Pfizer Process for obtaining substituted piperazines and piperidi
US4255426A (en) * 1979-07-09 1981-03-10 Pfizer Inc. 1-(2-Hydroxy-3-n-alkoxypropyl)-4-substituted-piperazines and piperidines
US4312877A (en) * 1979-07-09 1982-01-26 Pfizer Inc. 1-(2-Hydroxy-3-n-alkoxypropyl)-4-substituted piperidines, pharmaceutical compositions, thereof and use thereof
EP0094586A3 (en) * 1982-05-13 1984-06-06 Ono Pharmaceutical Co., Ltd. Glycerol derivatives, process for preparing same and pharmaceutical composition containing same
JPS5988447A (ja) * 1982-11-11 1984-05-22 Ono Pharmaceut Co Ltd グリセリン誘導体、その製造方法及びその誘導体を含有する薬剤
JPS60100544A (ja) * 1983-11-08 1985-06-04 Ono Pharmaceut Co Ltd 新規なグリセリン誘導体，その製造方法及びその誘導体を含有する薬剤
JPS60104066A (ja) * 1983-11-10 1985-06-08 Ono Pharmaceut Co Ltd グリセリン誘導体
JPS60105650A (ja) * 1983-11-14 1985-06-11 Ono Pharmaceut Co Ltd グリセリン誘導体、その製造方法及びその誘導体を含有する薬剤
JPS6164353A (ja) * 1984-09-04 1986-04-02 川崎重工業株式会社 湿式ミルの運転方法
JPS6194657A (ja) * 1984-10-16 1986-05-13 武田薬品工業株式会社 バイアル用ゴム栓
US4897355A (en) * 1985-01-07 1990-01-30 Syntex (U.S.A.) Inc. N[ω,(ω-1)-dialkyloxy]- and N-[ω,(ω-1)-dialkenyloxy]-alk-1-yl-N,N,N-tetrasubstituted ammonium lipids and uses therefor
US5545412A (en) * 1985-01-07 1996-08-13 Syntex (U.S.A.) Inc. N-[1, (1-1)-dialkyloxy]-and N-[1, (1-1)-dialkenyloxy]-alk-1-yl-n,n,n-tetrasubstituted ammonium lipids and uses therefor
CA1291036C (en) * 1986-04-23 1991-10-22 Edwin I. Stoltz Nasal administration of drugs
US4751245A (en) * 1986-06-25 1988-06-14 E. R. Squibb & Sons, Inc. Antifungal derivatives of N-(6,6-dimethyl-2-hepten-4-ynyl)-1-naphthalenemethanamine and method of using same
JPS63166237U (es) * 1987-04-16 1988-10-28
US5093198A (en) * 1987-06-19 1992-03-03 Temple University Adjuvant-enhanced sustained release composition and method for making
JPH0244750Y2 (es) * 1988-03-18 1990-11-28
AU614636B2 (en) * 1988-07-21 1991-09-05 Ciba Specialty Chemicals Holding Inc. Corrosion inhibition
US5176850A (en) * 1988-07-21 1993-01-05 Ciba-Geigy Corporation Substituted glycerol compounds
ZA899436B (en) * 1988-12-12 1990-08-29 Ciba Geigy Piperidine derivatives
JP2604268B2 (ja) * 1990-04-09 1997-04-30 富士写真フイルム株式会社 ペプチド誘導体両親媒性化合物、その中間体、ペプチド誘導体両親媒性化合物を用いたリポソームおよび薄膜
JPH0439597A (ja) * 1990-06-01 1992-02-10 Corona:Kk 給湯装置の熱交換器
DE19521412A1 (de) * 1995-06-14 1996-12-19 Boehringer Mannheim Gmbh Neue kationische und polykationische Amphiphile, diese enthaltende Reagenzien und deren Verwendung
DE19755268A1 (de) * 1997-12-12 1999-06-17 Merck Patent Gmbh Benzamidinderivate
GB0106041D0 (en) * 2001-03-12 2001-05-02 Cancer Res Ventures Ltd Lipids and liposomes
US7615604B2 (en) * 2003-01-17 2009-11-10 The United States Of America As Represented By The Secretary Of The Navy Diols formed by ring-opening of epoxies
US7622541B2 (en) * 2003-01-17 2009-11-24 The United States Of America As Represented By The Secretary Of The Navy Polyurethane coating
WO2009129387A2 (en) * 2008-04-16 2009-10-22 Abbott Laboratories Cationic lipids and uses thereof
WO2009129385A1 (en) * 2008-04-16 2009-10-22 Abbott Laboratories Cationic lipids and uses thereof
WO2009129395A1 (en) * 2008-04-16 2009-10-22 Abbott Laboratories Cationic lipids and uses thereof
EP2348864A4 (en) 2008-10-08 2013-07-31 Vascular Biogenics Ltd OXIDIZED THIOPHOSPHOLIPID COMPOUNDS AND USES THEREOF
RU2532546C2 (ru) * 2008-11-06 2014-11-10 Васкьюлар Байодженикс Лтд. Окисленные соединения липидов и их применение
EP3721943A1 (en) 2009-12-23 2020-10-14 Novartis AG Lipids, lipid compositions and methods of using them
ES2949172T3 (es) 2014-07-16 2023-09-26 Novartis Ag Método de encapsulamiento de un ácido nucleico en un hospedante de nanopartículas lipídicas
US9771385B2 (en) 2014-11-26 2017-09-26 Vascular Biogenics Ltd. Oxidized lipids
WO2016084023A1 (en) 2014-11-26 2016-06-02 Vascular Biogenics Ltd. Oxidized lipids and treatment or prevention of fibrosis

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2738351A (en) * 1952-08-02 1956-03-13 Bristol Lab Inc Substituted glycerol ethers
GB1013603A (en) * 1961-06-08 1965-12-15 Sandoz Ltd Level-dyeing process
GB1369248A (en) * 1970-08-07 1974-10-02 Pfizer Amides the preparation thereof and their use in pharmacjeutical compositions
US3960958A (en) * 1974-08-26 1976-06-01 Pfizer Inc. 3,4- AND 3,5-Dialkoxybenzylamines
US4025555A (en) * 1976-07-23 1977-05-24 Pfizer Inc. Aromatic amidines as antiviral agents in animals

Also Published As

Publication number Publication date
DD143902A5 (de) 1980-09-17
EG13438A (en) 1981-12-31
SE8401850D0 (sv) 1984-04-03
AT363922B (de) 1981-09-10
NO147670B (no) 1983-02-14
SE8401849L (sv) 1984-04-03
NO154344B (no) 1986-05-26
YU263082A (en) 1983-04-30
FR2414038A1 (fr) 1979-08-03
NO147300C (no) 1983-03-16
CH634544A5 (fr) 1983-02-15
NO782791L (no) 1979-02-20
SE447823B (sv) 1986-12-15
NL7808565A (nl) 1979-02-20
YU41277B (en) 1986-12-31
ES479616A1 (es) 1979-08-01
FR2414038B1 (es) 1982-07-02
NZ188174A (en) 1984-07-31
NL176670B (nl) 1984-12-17
JPS57167913A (en) 1982-10-16
BE869793A (fr) 1979-02-19
FR2421871B1 (es) 1982-07-02
GR73154B (es) 1984-02-13
SU906363A3 (ru) 1982-02-15
PH17789A (en) 1984-12-13
FI67687C (fi) 1985-05-10
JPS5829939B2 (ja) 1983-06-25
ATA600278A (de) 1981-02-15
SE463456B (sv) 1990-11-26
SE7808701L (sv) 1979-02-19
YU197478A (en) 1983-02-28
IT1098280B (it) 1985-09-07
NL176670C (nl) 1985-05-17
NO147670C (no) 1983-05-25
LU80114A1 (fr) 1980-04-21
NO813325L (no) 1979-02-20
AR219543A1 (es) 1980-08-29
IT7826813A0 (it) 1978-08-17
GB2005248A (en) 1979-04-19
NO147300B (no) 1982-12-06
US4166132A (en) 1979-08-28
YU41115B (en) 1986-12-31
PH16469A (en) 1983-10-21
IE47151B1 (en) 1983-12-28
DK149022B (da) 1985-12-23
CS208155B2 (en) 1981-08-31
PL116434B1 (en) 1981-06-30
YU41276B (en) 1986-12-31
JPS5924144B2 (ja) 1984-06-07
CA1102354A (en) 1981-06-02
NO154344C (no) 1986-09-03
MX6091E (es) 1984-11-12
DE2835369A1 (de) 1979-02-22
ES479615A1 (es) 1979-08-01
NO813324L (no) 1979-02-20
IL55370A (en) 1981-11-30
IN148386B (es) 1981-02-07
SU893128A3 (ru) 1981-12-23
PT68426A (en) 1978-09-01
DK321478A (da) 1979-02-19
DD148951A5 (de) 1981-06-17
SE8401850L (sv) 1984-04-03
JPS5441807A (en) 1979-04-03
IE781658L (en) 1979-02-18
DE2835369C2 (de) 1982-12-02
ES472659A1 (es) 1979-10-16
IL55370A0 (en) 1978-10-31
DK149022C (da) 1986-10-13
PH18067A (en) 1985-03-18
DE2857415C2 (de) 1985-02-07
SE8401849D0 (sv) 1984-04-03
JPS5929582B2 (ja) 1984-07-21
SU850005A3 (ru) 1981-07-23
AU503079B1 (en) 1979-08-23
JPS57167966A (en) 1982-10-16
HU181238B (en) 1983-06-28
PL209092A1 (pl) 1979-06-04
HU177884B (en) 1982-01-28
DE2857416C2 (de) 1984-05-24
PL115777B1 (en) 1981-04-30
PH18111A (en) 1985-03-22
PL116119B1 (en) 1981-05-30
GB2005248B (en) 1982-03-24
FR2421871A1 (fr) 1979-11-02
YU262982A (en) 1983-04-30
ZA783855B (en) 1979-07-25
FI782518A (fi) 1979-02-19
FI67687B (fi) 1985-01-31

Similar Documents

Publication Publication Date Title
AR218733A1 (es) Procedimiento para la preparacion de nuevos derivados de 1-(2,3-di(n-alquiloxi o n-alqueniloxi c12-c10)-propil)-4-aminometil-4-fenil-piperidina,y sus sales de adicion de acido farmaceuticamente aceptables,utiles para combatir las infecciones viricas en los mamiferos
AR226285A1 (es) Procedimiento para la preparacion de 2-aril-aminotiazoles y sus sales de adicion de acidos farmaceuticamente aceptables
AR226300A1 (es) Derivados del acido 4-(halo-2-quinolil o quinoxalil)-oxi)fenoxiacetico,procedimientos para producirlos y composicion herbicida que los contiene
IT1110885B (it) Procedimento per la preparazione di derivati dello acido ftalazin-4-ilacetico e prodotto ottenuto
DK148478A (da) Fremgangsmaade til fremstilling af cycloalkansubstituerede phenyleddikesyrederivater eller farmaceutisk acceptable salte eller estere deraf
AR224111A1 (es) Derivados de 1-oxido de acido penicilanico,desprovistos de actividad terapeutica,utiles como intermediarios en la preparacion de 1,1-dioxido de acido penicilanico farmaceuticamente activos,procedimiento para preparar dichos intermediarios y procedimiento para preparar los 1,1-dioxidos de acido penicilanico farmaceuticamente activos partiendo de dichos intermediarios
MX5477E (es) Procedimiento para la preparacion de derivados de acido pseudomonico
DK148745C (da) Ribofuranosylderivater til anvendelse som mellemprodukter ved fremstilling af 5'-deoxy-5-fluorcytidin eller 5'-deoxy-5-fluoruridin eller fysiologisk tolerable syreadditionssalte deraf
MX5877E (es) Procedimiento para la preparacion de derivados del acido piridiloxifenoxi-alfa-propionico
MX5149E (es) Procedimiento mejorado para la preparacion de derivados de acido cicloalquilidenmetilfenilacetico
AR222985A1 (es) Procedimiento para la preparacion de nuevos derivados de 9-hidrazono-4-oxo-6,7,8,9-tetrahidro-4h-pirido(1,2-a)pirimidina y sus sales
MX5971E (es) Procedimiento para la preparacion de derivados del acido acil glutamico
IT1107226B (it) Procedimento per la preparazione di derivati alogeno metilici di acido gamma-amminobutirrico utili come agenti farmacologici e prodotto ottenuto
AR228011A1 (es) Procedimiento para la preparacion de derivados sustituidos de 2,5,5,8a-tetrametil-1,2,3,4,4a,5,6,7,8,8a-decahidronaftaleno-1-spiro-2'-(4',6',7'-sustituido-2',3'-dihidrobenzofurano)
IT7820957A0 (it) Derivati di acido 1-azaxantone-3-carbossilico eprocedimento per la loro preparazione.
AR223314A1 (es) Derivados de 1-(fenilalquil)-imidazol-n,n'dimetil-4,5-dicarboxamidas,procedimientos para obtenerlos y composiciones herbicidas que los contienen
ES494086A0 (es) Procedimiento de preparacion de nuevos derivados halovinca- monas y de sus sales de adicion acidas farmaceuticamente aceptables e isomeros opticamente activos de los mismos
AR223015A1 (es) Procedimiento para la preparacion de nuevos derivados de 4-amino-2-(4-(1,4(5)-benzodioxaciclohexil(heptil)-2-carbonil)-piperazin-1-il)quinazolina y sus sales de adicion de acidos farmaceuticamente aceptables
IT7927962A0 (it) Procedimento per la preparazione di derivati dell'acido 7-amino-desacetossi cefalosporanico.
IT7852475A0 (it) Procedimento per la preparazione di acido salicilico e derivati
NO149352C (no) Azetidinonderivater for anvendelse som mellomprodukt ved fremstilling av farmakologisk aktive oksadetiacefalosporiner
IT7852240A0 (it) Procedimento per la preparazione di derivati di acido 1-idrocarbilpirro lo-2-acetico e prodotto ottenuto
IT1094614B (it) Derivati di acidi azolil-alcan-carbossilici,procedimento per la loro preparazione e loro impiego come funghicidi
IT1103493B (it) Procedimento per la cura farmacologica delle tossicomanie con composizioni di acido fusarico
ES509802A0 (es) Procedimiento para preparar antibioticos y antitumorigenos de la familia de bleomicina-fleomicina, designados ll-b01208 y ll-b01208 y las sales de adicion de acido farmaceuticamente aceptables de los mismos.